Why ProMIS Neurosciences Inc (PMN) Stock Is Rising
As of 2026-07-30, ProMIS Neurosciences Inc (PMN) has a next-year EPS growth estimate of 27.14%. Featured in our EPS revision report on 2026-07-30.
Why PMN Stock Is Rising
- +EPS Estimate Upgraded: Analysts raised ProMIS Neurosciences Inc's next-year EPS growth estimate from 26.67% to 27.14% on 2026-07-27.
- ·Current-Year Growth: Projected at 76.67%, supporting the forward estimate revision.
News Context
The primary driver of PMN's stock rise is an EPS estimate upgrade on July 27, 2026, where analysts raised next-year growth expectations from 26.67% to 27.14%. No headlines directly tie to an earnings beat or guidance raise; the most notable news is a planned webinar for upcoming Phase 1b trial data
Generated 2026-07-30 · news as of 2026-07-30
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 27.14%
- EPS growth this year
- 76.67%
- EPS next quarter (est)
- -$1.38
- Last price
- $15.21
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-07-30 | 27.14% | 76.67% | -$1.38 | $15.21 |
| 2026-07-29 | 27.14% | 76.67% | -$1.38 | $14.06 |
| 2026-07-28 | 27.14% | 76.67% | -$1.38 | $14.52 |
| 2026-07-27 | 27.14% | 76.67% | -$1.38 | $11.72 |
| 2026-07-26 | 26.67% | 76.36% | -$1.41 | $12.20 |
| 2026-07-24 | 26.67% | 76.36% | -$1.41 | $12.20 |
| 2026-07-23 | 26.67% | 76.36% | -$1.41 | $12.61 |
| 2026-07-22 | 26.67% | 76.36% | -$1.41 | $13.99 |
| 2026-07-21 | 26.67% | 76.36% | -$1.41 | $14.49 |
| 2026-07-20 | 26.67% | 76.36% | -$1.41 | $15.07 |
| 2026-07-19 | 26.67% | 76.36% | -$1.41 | $15.19 |
| 2026-07-17 | 26.67% | 76.36% | -$1.41 | $15.19 |
| 2026-07-16 | 26.67% | 76.36% | -$1.41 | $13.30 |
| 2026-07-15 | 26.67% | 76.36% | -$1.41 | $14.01 |
| 2026-07-14 | 26.67% | 76.36% | -$1.41 | $13.66 |
| 2026-07-13 | 26.67% | 76.36% | -$1.41 | $12.80 |
| 2026-07-12 | 26.67% | 76.36% | -$1.41 | $14.25 |
| 2026-07-09 | 26.67% | 76.36% | -$1.41 | $14.27 |
| 2026-07-08 | 26.67% | 76.36% | -$1.41 | $13.78 |
| 2026-07-07 | 32.84% | 76.00% | -$1.44 | $13.55 |
| 2026-07-06 | 32.84% | 76.00% | -$1.44 | $13.71 |
| 2026-07-05 | 32.84% | 76.00% | -$1.44 | $13.35 |
| 2026-07-02 | 32.84% | 76.00% | -$1.44 | $13.35 |
| 2026-07-01 | 32.84% | 76.00% | -$1.44 | $13.45 |
| 2026-06-30 | 32.84% | 76.00% | -$1.44 | $13.16 |
| 2026-05-18 | 33.33% | 76.38% | -$1.41 | $10.55 |
| 2026-05-17 | 33.33% | 76.38% | -$1.41 | $10.39 |
| 2026-03-25 | 65.13% | N/A | N/A | $15.85 |
| 2026-03-25 | 30.07% | N/A | N/A | $15.85 |
| 2026-03-25 | 30.07% | N/A | N/A | $15.85 |
Reports Featuring PMN
Recent News
Screen Performance
Aggregate stats across all 1894 tickers our top-EPS-revision screen has flagged over the past 120 days.
- Median return since detection
- +1.3%
- % of tickers in the green
- 53%
- Median return on winners
- +19.6%
- Large revisions captured
- 1170
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
Why did ProMIS Neurosciences Inc (PMN) stock go up recently?▾
ProMIS Neurosciences Inc (PMN) stock has risen following an analyst upgrade of its next-year EPS growth estimate from 26.67% to 27.14% on 2026-07-27. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.
What is ProMIS Neurosciences Inc's next-year EPS growth estimate?▾
As of 2026-07-30, ProMIS Neurosciences Inc (PMN) has a next-year EPS growth estimate of 27.14%, based on analyst consensus.
When was the latest EPS estimate revision for PMN?▾
The most recent revision occurred on 2026-07-27, when analysts adjusted the next-year EPS growth estimate from 26.67% to 27.14%.
What sector and industry does ProMIS Neurosciences Inc belong to?▾
ProMIS Neurosciences Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. PMN appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. ProMIS Neurosciences Inc (PMN) appears here because it was detected by our daily top-EPS-revision-performer screen.